Halozyme Therapeutics Revenue 2010-2024 | HALO
- Halozyme Therapeutics annual revenue for 2023 was $0.829B, a 25.62% increase from 2022.
- Halozyme Therapeutics annual revenue for 2022 was $0.66B, a 48.91% increase from 2021.
- Halozyme Therapeutics annual revenue for 2021 was $0.443B, a 65.67% increase from 2020.